Preoperative Temporary Discontinuation of Aspirin Medication Does Not Increase the Allogeneic Transfusion Rate and Blood Loss in Primary Total Hip Arthroplasty.
Myung-Rae ChoChung Mu JunWon-Kee ChoiPublished in: Hip & pelvis (2019)
Preoperative temporary discontinuation of aspirin use for 7 days before surgery did not increase initial blood loss after THA and the need for transfusion in the first two postoperative weeks compared to patients with no history of use of antiplatelet agents.
Keyphrases
- patients undergoing
- total hip arthroplasty
- low dose
- cardiac surgery
- cardiovascular events
- antiplatelet therapy
- stem cell transplantation
- minimally invasive
- sickle cell disease
- coronary artery bypass
- bone marrow
- healthcare
- acute kidney injury
- anti inflammatory drugs
- cardiovascular disease
- acute coronary syndrome
- surgical site infection
- type diabetes
- adverse drug
- hematopoietic stem cell